Bilateral phrenic nerve paralysis as a manifestation of paraneoplastic syndrome.
Otrock
Zaher K
ZK
Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Barada
Wissam M
WM
Sawaya
Raja A
RA
Saab
Jad F
JF
Bazarbachi
Ali A
AA
D000230:Adenocarcinoma / Q000150:complications* / Q000628:therapy; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000150:complications* / Q000628:therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D000077143:Docetaxel; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D010243:Paralysis / Q000209:etiology*; D020361:Paraneoplastic Syndromes, Nervous System / Q000209:etiology / Q000503:physiopathology*; D010791:Phrenic Nerve / Q000473:pathology*; D012131:Respiratory Insufficiency / Q000209:etiology; D043823:Taxoids / Q000008:administration & dosage; D000068878:Trastuzumab; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077235:Vinorelbine
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D043823:Taxoids; D000077143:Docetaxel; D014747:Vinblastine; D004317:Doxorubicin; D003520:Cyclophosphamide; D000068878:Trastuzumab; D000077235:Vinorelbine; D005472:Fluorouracil